FIRST EUROPEAN IMPLANTATION OF GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS

Feb 1, 2024

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

Jan 16, 2024

GORE INITIATES STUDY TO EVALUATE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS AS BRIDGING STENT

Feb 16, 2023

GORE COMPLETES ENROLLMENT IN THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS EXPAND REGISTRY

This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases.

Oct 27, 2022

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

CAUTION: Investigational device. Limited by United States law to investigational use.

Apr 12, 2022

FIRST EUROPEAN IMPLANTS FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS PIVOTAL STUDY

Nov 23, 2021

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study

Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure

Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion May Reduce Portal Hypertension Readmissions in Ongoing Study

First Patients Enrolled in the Gore RELINE MAX Clinical Study

108 patient trial to add evidence for treatment of in-stent restenosis using the GORE® VIABAHN® Endoprosthesis